{"id":{"repo_id":"mcmaster","oai_identifier":"oai:macsphere.mcmaster.ca:11375/33615"},"canonical_url":"https://search.ndltd.org/etd/mcmaster/oai:macsphere.mcmaster.ca:11375/33615","repository":{"repo_id":"mcmaster","name":"McMaster University","base_url":"https://macsphere.mcmaster.ca/server/oai/request"},"display":{"title":"Assessment of Informed Consent Practices in Randomized Controlled Trials Conducted in Maternal and Child Health: A Methodological Study","abstract":"Abstract Introduction: Informed consent is a crucial ethical pillar in randomized controlled trials (RCTs) that promotes informed decision-making in participants. Pre-screening is commonly used to narrow potential participants prior to obtaining consent in RCTs. Although, pre-screening is a time- and cost-efficient process, its use in maternal and child health (MCH) RCTs pose ethical concerns, as clinical decisions are often time-sensitive. Objectives: To examine consent timing and reporting, approaches to pre-screening and screening, and determine factors associated with the completeness of pre-screening reporting. Methods: Chapter One highlights current informed consent practices and guidelines, and the importance of higher ethical standards for MCH populations. Chapter Two describes a methodological review of 250 MCH RCTs. Findings were analyzed descriptively with counts, percentages and a multivariable logistic regression to determine factors associated with completeness of pre-screening reporting. Chapter Three discusses the implications of findings from this methodological review and existing literature to advice recommendations to enhance ethical and RCT reporting guidelines. Results: Literature review identified that pre-screening guidelines are not standardized despite their wide use in RCTs. Of the 250 MCH RCTs analyzed, 186 (74.4%) studies conducted pre-screening in addition to screening, and 64 (25.6%) studies conducted screening only. During pre-screening, 61.8% collected moderately sensitive-, and 13.4% collected highly sensitive personal data. Only 26.9% provided complete pre-screening reporting. Multivariable logistic regression revealed no association of complete pre-screening reporting with publication year, World Health Organization region, inclusion of consent in eligibility criteria, and reporting of participant flow diagram. Thirdly, a collaborative effort from researchers, ethics review boards, and the MCH community is proposed to improve consent practices and pre-screening reporting. Conclusion: Although pre-screening is a common practice in MCH RCTs, it involves accessing sensitive personal data before formal trial consent is obtained and is often incompletely reported. This thesis proposes approaches to improve pre-screening reporting guidelines.","abstract_html":"Abstract Introduction: Informed consent is a crucial ethical pillar in randomized controlled trials (RCTs) that promotes informed decision-making in participants. Pre-screening is commonly used to narrow potential participants prior to obtaining consent in RCTs. Although, pre-screening is a time- and cost-efficient process, its use in maternal and child health (MCH) RCTs pose ethical concerns, as clinical decisions are often time-sensitive. Objectives: To examine consent timing and reporting, approaches to pre-screening and screening, and determine factors associated with the completeness of pre-screening reporting. Methods: Chapter One highlights current informed consent practices and guidelines, and the importance of higher ethical standards for MCH populations. Chapter Two describes a methodological review of 250 MCH RCTs. Findings were analyzed descriptively with counts, percentages and a multivariable logistic regression to determine factors associated with completeness of pre-screening reporting. Chapter Three discusses the implications of findings from this methodological review and existing literature to advice recommendations to enhance ethical and RCT reporting guidelines. Results: Literature review identified that pre-screening guidelines are not standardized despite their wide use in RCTs. Of the 250 MCH RCTs analyzed, 186 (74.4%) studies conducted pre-screening in addition to screening, and 64 (25.6%) studies conducted screening only. During pre-screening, 61.8% collected moderately sensitive-, and 13.4% collected highly sensitive personal data. Only 26.9% provided complete pre-screening reporting. Multivariable logistic regression revealed no association of complete pre-screening reporting with publication year, World Health Organization region, inclusion of consent in eligibility criteria, and reporting of participant flow diagram. Thirdly, a collaborative effort from researchers, ethics review boards, and the MCH community is proposed to improve consent practices and pre-screening reporting. Conclusion: Although pre-screening is a common practice in MCH RCTs, it involves accessing sensitive personal data before formal trial consent is obtained and is often incompletely reported. This thesis proposes approaches to improve pre-screening reporting guidelines.","abstract_has_math":false,"creators":["Joshi, Mahima"],"institution":"McMaster University","degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":"Clinical Health Sciences (Health Research Methodology)","school":null,"contributors":[],"advisors":["Mbuagbaw, Lawrence"],"committee_chairs":[],"committee_members":[],"year":2026,"date_issued":"2026","date_published":"2026","updated_at":"2026-11-18T19:30:30Z","subjects":[],"languages":["en"],"rights":[],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://doi.org/10.71548/25386"],"render_values":[{"text":"https://doi.org/10.71548/25386","href":"https://doi.org/10.71548/25386","code":true}]}],"person_identifier_entries":[]},"links":{"outbound_url":"https://hdl.handle.net/11375/33615","outbound_label":"Handle","outbound_source":"dc:identifier.uri","record_url":"https://hdl.handle.net/11375/33615","record_label":"Repository record","record_kind":"handle","record_source":"dc:identifier.uri","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://macsphere.mcmaster.ca/server/oai/request?verb=GetRecord&metadataPrefix=dim&identifier=oai%3Amacsphere.mcmaster.ca%3A11375%2F33615","prefix":"dim"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.advisor","label":"Advisor","values":["Mbuagbaw, Lawrence"]},{"key":"dc:contributor.department","label":"Department","values":["Clinical Health Sciences (Health Research Methodology)"]},{"key":"dc:creator","label":"Author","values":["Joshi, Mahima"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2026-09-29T19:24:57Z"]},{"key":"dc:date.issued","label":"Date","values":["2026"]},{"key":"dc:publisher","label":"Institution","values":["McMaster University"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.iso","label":"Language (ISO)","values":["en"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://hdl.handle.net/11375/33615","https://doi.org/10.71548/25386"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Abstract Introduction: Informed consent is a crucial ethical pillar in randomized controlled trials (RCTs) that promotes informed decision-making in participants. Pre-screening is commonly used to narrow potential participants prior to obtaining consent in RCTs. Although, pre-screening is a time- and cost-efficient process, its use in maternal and child health (MCH) RCTs pose ethical concerns, as clinical decisions are often time-sensitive. Objectives: To examine consent timing and reporting, approaches to pre-screening and screening, and determine factors associated with the completeness of pre-screening reporting. Methods: Chapter One highlights current informed consent practices and guidelines, and the importance of higher ethical standards for MCH populations. Chapter Two describes a methodological review of 250 MCH RCTs. Findings were analyzed descriptively with counts, percentages and a multivariable logistic regression to determine factors associated with completeness of pre-screening reporting. Chapter Three discusses the implications of findings from this methodological review and existing literature to advice recommendations to enhance ethical and RCT reporting guidelines. Results: Literature review identified that pre-screening guidelines are not standardized despite their wide use in RCTs. Of the 250 MCH RCTs analyzed, 186 (74.4%) studies conducted pre-screening in addition to screening, and 64 (25.6%) studies conducted screening only. During pre-screening, 61.8% collected moderately sensitive-, and 13.4% collected highly sensitive personal data. Only 26.9% provided complete pre-screening reporting. Multivariable logistic regression revealed no association of complete pre-screening reporting with publication year, World Health Organization region, inclusion of consent in eligibility criteria, and reporting of participant flow diagram. Thirdly, a collaborative effort from researchers, ethics review boards, and the MCH community is proposed to improve consent practices and pre-screening reporting. Conclusion: Although pre-screening is a common practice in MCH RCTs, it involves accessing sensitive personal data before formal trial consent is obtained and is often incompletely reported. This thesis proposes approaches to improve pre-screening reporting guidelines."]},{"key":"dc:description.degree","label":"Dc Description Degree","values":["Master of Health Sciences (MSc)"]},{"key":"dc:title","label":"Title","values":["Assessment of Informed Consent Practices in Randomized Controlled Trials Conducted in Maternal and Child Health: A Methodological Study"]},{"key":"others:access_status","label":"Others Access Status","values":["open.access"]}]}],"canonical_facts":{"dc:contributor.advisor":["Mbuagbaw, Lawrence"],"dc:contributor.department":["Clinical Health Sciences (Health Research Methodology)"],"dc:creator":["Joshi, Mahima"],"dc:date.accessioned":["2026-09-29T19:24:57Z"],"dc:date.issued":["2026"],"dc:description.abstract":["Abstract Introduction: Informed consent is a crucial ethical pillar in randomized controlled trials (RCTs) that promotes informed decision-making in participants. Pre-screening is commonly used to narrow potential participants prior to obtaining consent in RCTs. Although, pre-screening is a time- and cost-efficient process, its use in maternal and child health (MCH) RCTs pose ethical concerns, as clinical decisions are often time-sensitive. Objectives: To examine consent timing and reporting, approaches to pre-screening and screening, and determine factors associated with the completeness of pre-screening reporting. Methods: Chapter One highlights current informed consent practices and guidelines, and the importance of higher ethical standards for MCH populations. Chapter Two describes a methodological review of 250 MCH RCTs. Findings were analyzed descriptively with counts, percentages and a multivariable logistic regression to determine factors associated with completeness of pre-screening reporting. Chapter Three discusses the implications of findings from this methodological review and existing literature to advice recommendations to enhance ethical and RCT reporting guidelines. Results: Literature review identified that pre-screening guidelines are not standardized despite their wide use in RCTs. Of the 250 MCH RCTs analyzed, 186 (74.4%) studies conducted pre-screening in addition to screening, and 64 (25.6%) studies conducted screening only. During pre-screening, 61.8% collected moderately sensitive-, and 13.4% collected highly sensitive personal data. Only 26.9% provided complete pre-screening reporting. Multivariable logistic regression revealed no association of complete pre-screening reporting with publication year, World Health Organization region, inclusion of consent in eligibility criteria, and reporting of participant flow diagram. Thirdly, a collaborative effort from researchers, ethics review boards, and the MCH community is proposed to improve consent practices and pre-screening reporting. Conclusion: Although pre-screening is a common practice in MCH RCTs, it involves accessing sensitive personal data before formal trial consent is obtained and is often incompletely reported. This thesis proposes approaches to improve pre-screening reporting guidelines."],"dc:description.degree":["Master of Health Sciences (MSc)"],"dc:identifier.uri":["https://hdl.handle.net/11375/33615","https://doi.org/10.71548/25386"],"dc:language.iso":["en"],"dc:publisher":["McMaster University"],"dc:title":["Assessment of Informed Consent Practices in Randomized Controlled Trials Conducted in Maternal and Child Health: A Methodological Study"],"dc:type":["Thesis"],"others:access_status":["open.access"]},"updated_at":"2026-11-18T19:30:30Z"}